Active Ingredient: LOTEPREDNOL ETABONATE
Proprietary Name: LOTEPREDNOL ETABONATE
Dosage Form; Route of Administration: SUSPENSION/DROPS; OPHTHALMIC
Strength: 0.2%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A215550
Product Number: 001
Approval Date: Dec 26, 2023
Applicant Holder Full Name: LUPIN LTD
Marketing Status:
Prescription
Patent and Exclusivity Information